SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-15-010797
Filing Date
2015-11-16
Accepted
2015-11-16 16:00:22
Documents
3
Period of Report
2015-11-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cdtx-8k_20151116.htm 8-K 30400
2 EX-99.1 cdtx-ex991_114.htm EX-99.1 163125
3 GRAPHIC g201511161830167525667.jpg GRAPHIC 4097
  Complete submission text file 0001564590-15-010797.txt   200597
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36912 | Film No.: 151234180
SIC: 2836 Biological Products, (No Diagnostic Substances)